Skip to main content

InfuSystem Holdings, Inc

INFU
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001337013

No open-market purchases or sales by InfuSystem Holdings, Inc insiders were filed in the last 90 days; 100 institutions reported holding it in 13F filings for Q2 2026, worth $146.0M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding InfuSystem Holdings, Inc changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of INFU: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders78167−10
Shares12.3M2.96K11.3M−972.3K (−7.9%)
Value$120.1M$29.0K$108.5M−$11.6M (−9.6%)

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (10)

Institutions that held InfuSystem Holdings, Inc at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to INFU in Q2 2022
InstitutionSharesValue% of portfolio
Cove Street Capital, LLC407,515$3.92M0.99%
Kent Lake Capital LLC200,433$1.93M1.06%
Millennium Management LLC170,795$1.65M0.00%
Ergoteles LLC77,800$749.0K0.02%
Pinz Capital Management, LP67,720$652.0K0.45%
Algert Global LLC19,746$190.0K0.01%
Qube Research & Technologies Ltd14,070$135.0K0.00%
Standard Family Office LLC2,000$19.0K0.19%
Total Clarity Wealth Management, Inc.984$9.00K0.00%
Credit Suisse AG10$00.00%

Sold out (20)

Institutions that held InfuSystem Holdings, Inc at the end of Q1 2022 and filed for Q2 2022 without it.

Not filed for Q2 2022 yet (1)

Institutions that held InfuSystem Holdings, Inc at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding INFU in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Amalgamated Financial Corp.2,958$29.0K